Abstract
National and international consortia will play a key role in understanding the effects of the coronavirus disease 2019 (COVID-19) pandemic on cancer patients. The COVID-19 and Cancer Consortium (CCC19) aims to collect and analyze observational data at scale to inform clinical practice in real-time.
Copyright © 2020 Elsevier Inc. All rights reserved.
MeSH terms
-
Betacoronavirus / isolation & purification*
-
Betacoronavirus / pathogenicity
-
COVID-19
-
Canada
-
Clinical Decision-Making
-
Coronavirus Infections / complications
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / therapy*
-
Coronavirus Infections / virology
-
Crowdsourcing
-
Drug Repositioning
-
Humans
-
International Cooperation
-
Intersectoral Collaboration
-
Medical Oncology / organization & administration*
-
Neoplasms / complications
-
Neoplasms / therapy*
-
Pandemics
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / therapy*
-
Pneumonia, Viral / virology
-
Registries*
-
SARS-CoV-2
-
Spain
-
United States